Drugs that initiate myeloid differentiation are already used in therapy to treat promyelocytic leukemia and a restoration of reduced GFI1 expression to normal levels would have a similar and potentially therapeutic effect [43]. Here, GFI1 is linked to acute promyelocytic leukemia.